<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20260916071083N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2026-09-30</date_registration>
      <primary_sponsor>Superior university lahore</primary_sponsor>
      <public_title>“Individualized Versus Fixed Positive End- Expiratory Pressure (PEEP) in patients Undergoing Laparoscopic Surgery ”</public_title>
      <acronym></acronym>
      <scientific_title>“Individualized Versus Fixed Positive End- Expiratory Pressure (PEEP) in patients Undergoing Laparoscopic Surgery ”</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2026-08-14</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>96</target_size>
      <recruitment_status>Recruiting</recruitment_status>
      <url>https://irct.ir/trial/93448</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Not blinded, Placebo: Not used, Assignment: Parallel, Purpose: Treatment, Other design features: Two-arm parallel-group randomized controlled clinical trail comparing individualized versus fixed positive end expiratory pressure (PEEP ) in patient undergoing laparoscopic surgery , Randomization description: Eligible patients fulfilling the inclusion criteria will be recruited consecutively until the required sample size is achieved. After obtaining informed consent, participants will be randomly allocated to either the Fixed PEEP group (5 cmH₂O) or the Individualized PEEP group using a computer-generated randomization sequence. Allocation concealment will be maintained using sealed opaque envelopes.</study_design>
      <phase>N/A</phase>
      <hc_freetext>Methodology: Randomized Controlled Trial (RCT) will be conducted over four months in the operation theatres of the Department of Anesthesiology at Ayub Teaching Hospital Abbottabad. Patients aged 20 to 65 years, classified as American Society of Anaesthesiology..</hc_freetext>
      <i_freetext>Intervention group:.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Yes - There is a plan to make this available</results_IPD_plan>
      <results_IPD_description>What will be shared:
Individualized Versus Fixed Positive End-Expiratory Pressure (PEEP) in Patients Undergoing Laparoscopic Surgery – Study Data De-identified individual participant data (IPD) collected during the study will be shared. The dataset will include demographic and clinical characteristics, intraoperative ventilation parameters (including PEEP, tidal volume, FiO₂, peak airway pressure, lung compliance, plateau pressure, and driving pressure), arterial blood gas measurements including PaO₂/FiO₂ ratio and PaCO₂, and postoperative outcomes including oxygen saturation, atelectasis, and pulmonary complications. No directly identifiable participant information will be included.

When:
The de-identified individual participant data and related study documents will become available after completion of the study and publication or public availability of the study’s summary results. The data will remain available for a period of 5 years following publication of the primary study results. Access will be subject to applicable ethical, confidentiality, and institutional requirements.

To whom:
Deidentified individual participant data (IPD) and relevant supporting study documents will be shared with qualified researchers and investigators for legitimate scientific and academic research purposes. Requests may be considered from researchers affiliated with academic institutions, healthcare institutions, research organizations, and other organizations, including businesses, provided that the proposed use is scientifically and ethically appropriate. Data will only be shared in a deidentified form and in accordance with applicable ethical, confidentiality, and institutional requirements.

Conditions:
Deidentified individual participant data (IPD) and supporting study documents will be made available upon reasonable request for legitimate scientific and academic research purposes, including secondary analyses related to perioperative ventilation, individualized PEEP, oxygenation, respiratory mechanics, and postoperative pulmonary outcomes. Requests will be reviewed by the study investigator and, where required, the relevant institutional/ethical authority to ensure that the proposed use is scientifically appropriate and complies with ethical and confidentiality requirements. Data will be provided only in deidentified form. Access will be subject to applicable institutional policies and data-sharing requirements.

Where to obtain:
Applicants wishing to request access to the deidentified individual participant data (IPD) or supporting study documents should contact the study investigator through the research/academic office of The Superior University Lahore. Requests should preferably be submitted by email and should include the applicant’s name, institutional affiliation, contact information, purpose of the proposed data use, and a brief description of the intended analysis.
Contact person: Uzair Mustajab, Student Investigator
Supervisor: Dr. Usra Naeem
Institution: The Superior University Lahore, Faculty of Allied Health Sciences
Email: uzairjahangere675@gmail.com
Telephone:+923135156669

How to obtain:
Applicants should submit a request by email, including their affiliation, purpose of data use, and intended analysis. Requests will be reviewed for ethical and confidentiality requirements. Approved deidentified data will be shared securely within approximately 3–6 weeks of receiving a complete request

Comments:
All shared data will be deidentified and provided in accordance with applicable ethical, confidentiality, and institutional requirements. The study investigator reserves the right to decline requests that do not meet these requirements.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Dr Usra Naeem</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>17km raiwand road,kot araian lahore</address>
        <city>lahore</city>
        <country1>Pakistan</country1>
        <zip>55150</zip>
        <telephone>+92 333 4381978</telephone>
        <email>uzairjahangere675@gmail.com</email>
        <affiliation>Superior university lahore</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>dr usra naeem</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>raiwand road,kot araian lahore</address>
        <city>lahore</city>
        <country1>Pakistan</country1>
        <zip>55150</zip>
        <telephone>+92 333 4381978</telephone>
        <email>usra.naeem@superior.edu.pk</email>
        <affiliation>Superior university lahore</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Pakistan</country2>
    </countries>
    <criteria>
      <inclusion_criteria>Patients aged 20–65 years.
ASA physical status I–III.
Scheduled for elective laparoscopic Surgery.
Willingness to participate and provide informed consent</inclusion_criteria>
      <agemin>20 years</agemin>
      <agemax>65 years</agemax>
      <gender>Both</gender>
      <exclusion_criteria>•	Patients with progressive neuromuscular disease.
•	Known difficult airway.
•	Pregnancy.
•	BMI &gt;35 kg/m²
•	Severe COPD
•	Severe cardiac disease
•	Emergency surgeries.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code></hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword></hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Other</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group:</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>To compare the effect of individualized PEEP versus fixed PEEP on intraoperative. Timepoint: Before intervention (baseline) and intraoperatively after application of the PEEP intervention, at 30 minutes, 60 minutes, and at the end of surgery. Method of measurement: “PaO₂/FiO₂ ratio will be measured using arterial blood gas (ABG) analysis, with PaO₂ obtained from the ABG analyzer and divided by the corresponding FiO₂.”.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>The Superior University Lahore,</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2026-08-24</approval_date>
        <contact_name>Superior university lahore</contact_name>
        <contact_address>17km raiwand road,kot araian lahore lahore punjab Pakistan</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
